Elevated serum afamin levels in prediabetes and type 2 diabetes patients are closely associated with liver lipid accumulation and liver injury, suggesting afamin’s potential as a biomarker (Kurdiova et al., 2021). The gene discussed is AFM; the disease is type 2 diabetes mellitus.